Department of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Department of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Curr Opin Biotechnol. 2019 Aug;58:1-8. doi: 10.1016/j.copbio.2018.10.005. Epub 2018 Nov 1.
Nanoparticulate platforms have contributed significantly to the field of biomedical research, demonstrating advantages over traditional modalities in areas such as drug delivery, detoxification, and vaccination. When it comes to the design of nanoparticles, biomimetic strategies have become increasingly popular as a means of promoting effective interactions with biological systems. A recently developed cell membrane-coated nanoparticle platform can leverage the natural interactions that cells engage in with other cells, the extracellular matrix, and biomolecules in order to reduce undesirable nonspecific interactions, while increasing target-specific interactions. Here, we discuss the current state of these biomimetic nanoparticles and highlight how they can be used for various biomedical applications.
纳米颗粒平台在生物医药研究领域做出了重大贡献,在药物输送、解毒和疫苗接种等领域优于传统模式。在设计纳米颗粒时,仿生策略已成为促进与生物系统有效相互作用的一种越来越受欢迎的手段。最近开发的细胞膜包覆的纳米颗粒平台可以利用细胞与其他细胞、细胞外基质和生物分子之间的自然相互作用,减少不必要的非特异性相互作用,同时增加靶特异性相互作用。在这里,我们讨论了这些仿生纳米颗粒的现状,并强调了它们如何用于各种生物医药应用。